These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20457281)

  • 1. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
    Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
    Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
    J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells.
    Le Pottier L; Devauchelle V; Fautrel A; Daridon C; Saraux A; Youinou P; Pers JO
    J Immunol; 2009 Mar; 182(6):3540-7. PubMed ID: 19265132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
    Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
    Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P
    Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-lymphocytes govern the pathogenesis of Sjögren's syndrome.
    Youinou P; Saraux A; Pers JO
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2071-7. PubMed ID: 22208653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.
    Szodoray P; Alex P; Jonsson MV; Knowlton N; Dozmorov I; Nakken B; Delaleu N; Jonsson R; Centola M
    Clin Immunol; 2005 Nov; 117(2):168-76. PubMed ID: 16126006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
    Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
    Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
    Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
    Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [B lymphocytes in Sjögren's syndrome].
    Pers JO; Le Pottier L; Devauchelle V; Saraux A; Youinou P
    Rev Med Interne; 2008 Dec; 29(12):1000-6. PubMed ID: 18403061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
    Szodoray P; Jonsson R
    Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
    Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
    J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-targeted therapies in Sjögren's syndrome.
    Tobón GJ; Pers JO; Youinou P; Saraux A
    Autoimmun Rev; 2010 Feb; 9(4):224-8. PubMed ID: 19671451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary tumours in Sjögren's syndrome.
    Kovács L; Szodoray P; Kiss E
    Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
    Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
    J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.